Lundbeck
HLUN-B.CO
#2798
Rank
โ‚น555.57 B
Marketcap
โ‚น559.97
Share price
-2.55%
Change (1 day)
18.74%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

Earnings for Lundbeck (HLUN-B.CO)

Earnings in 2025 (TTM): โ‚น66.53 Billion

According to Lundbeck's latest financial reports the company's current earnings are โ‚น3.80 Billion. , an increase over its 2024 earnings that were of โ‚น50.36 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Lundbeck from 2009 to 2025

Annual earnings

Year Earnings Change
2025 โ‚น69.74 B38.47%
2024 โ‚น50.36 B25.74%
2023 โ‚น40.05 B21.77%
2022 โ‚น32.89 B31.57%
2021 โ‚น25.00 B-4.61%
2020 โ‚น26.20 B-45.06%
2019 โ‚น47.70 B-34.04%
2018 โ‚น72.33 B12.83%
2017 โ‚น64.10 B93.99%
2016 โ‚น33.04 B-137.28%
2015 -โ‚น88.65 Billion-1246.24%
2014 โ‚น7.73 B-72.36%
2013 โ‚น27.97 B4.38%
2012 โ‚น26.80 B-55.18%
2011 โ‚น59.80 B5.65%
2010 โ‚น56.60 B-5.9%
2009 โ‚น60.15 B